Avita announces $10m capital raising plan

05/09/2012 - 15:23

Bookmark

Save articles for future reference.
Avita announces $10m capital raising plan

Medical research firm Avita Medical has announced a proposal to raise up to $10 million, with Octa Phillip Bioscience Managers committing to tip in $3 million.

Avita today announced a $10 million placement and share purchase plan for existing shareholders, priced at 12 cents per share.

The placement will comprise two tranches, one at $4 million and the other for a minimum of $2.3 million.

The $3.7 million balance will be raised through the purchase plan, Avita said.

Avita also said significant investor Australian Ethical Investment had committed to take a further $1.5 million stake through the share placement.

The company said the proceeds would be used to fund the completion of US trials of its ReCell Spray-On Skin technology.

“This investment proposition will distinguish Avita from other smaller companies by presenting the full funding plan and operational outlook through to 2014,” chief executive William Dolphin said.

“Securing a new cornerstone investor of the calibre of Octa Phillip Bioscience Manager, plus reconfirmation of Australian Ethical Investment support, is a validation of management’s strategic approach in the building of a strong market base for the ReCell technology and testament to the clinical and revenue-generating prospects of the company over the coming years.”

At close of trade today, Avita stocks were down 7.1 per cent to 13 cents.
 

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options